TWI379684B - - Google Patents

Download PDF

Info

Publication number
TWI379684B
TWI379684B TW096119746A TW96119746A TWI379684B TW I379684 B TWI379684 B TW I379684B TW 096119746 A TW096119746 A TW 096119746A TW 96119746 A TW96119746 A TW 96119746A TW I379684 B TWI379684 B TW I379684B
Authority
TW
Taiwan
Prior art keywords
extract
maitake
alcohol
skin
weight
Prior art date
Application number
TW096119746A
Other languages
Chinese (zh)
Other versions
TW200806304A (en
Inventor
Akira Ito
Takashi Sato
Noriko Akimoto
Masao Takahashi
Original Assignee
Heimat Co Ltd
Akira Ito
Takashi Sato
Noriko Akimoto
Masao Takahashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heimat Co Ltd, Akira Ito, Takashi Sato, Noriko Akimoto, Masao Takahashi filed Critical Heimat Co Ltd
Priority to TW096119746A priority Critical patent/TW200806304A/en
Publication of TW200806304A publication Critical patent/TW200806304A/en
Application granted granted Critical
Publication of TWI379684B publication Critical patent/TWI379684B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Description

1379684 24570pi f1 爲第96119746號中文說明書無劃線修正本 六、發明說明: 【發明所屬之技術領域】 本發明是有關於一種新的舞茸萃取物以及包含此萃 取物之促進皮脂產生的組成物。 【先前技術】 脂腺是附屬於皮膚,可分滿出被稱爲皮墙的油狀物 質,而在表皮表面形成一種非滲透性的保護祺。皮脂則是 由脂質混合物所形成,其含有甘油三g旨、角娑成 '1379684 24570pi f1 is the Chinese manual of No. 96119746. There is no slash correction. The present invention relates to a new Maitake extract and a composition for promoting sebum production comprising the same. . [Prior Art] The gland is attached to the skin and can be divided into an oily substance called a leather wall to form a non-permeable protective flaw on the surface of the epidermis. Sebum is formed from a mixture of lipids, which contains glycerol

0廣、崎、脂肪族 蠟、游離脂肪酸、膽固醇類等。 另外,皮脂還具有保濕作用,可以讓表皮柔軟、 同時,皮脂又擔任著增強皮膚強度的重要任務。 脂還有防止紫外線造成的表皮受傷,保護皮 3 ^ , 變態反應原的入侵的作用。 不又異物和 由於年齡的增長及㈣_等原因會使得皮脂產生 此力下降,從而引起皮膚雜和強度下降 力也隨之下降。特別是,皮脂產生能 ^貝傷的抵抗0 Guang, Saki, aliphatic wax, free fatty acids, cholesterol and so on. In addition, sebum also has a moisturizing effect, which makes the epidermis soft, and at the same time, sebum plays an important role in enhancing skin strength. Lipid also protects against epidermal damage caused by UV rays, protects the skin 3 ^, and invades the allergens. Not only foreign matter and due to age and (4) _, etc., the sebum produces this force, which causes the skin's heterogeneity and strength to decrease. In particular, sebum produces resistance to scallops

修正曰期101年8月24曰 乾燥等皮膚赫的軸賴。 的下降’也是皮膚 乂 /田眼的職妝、兑油酸和播 ^報)4作爲促進皮脂產生叫效成分已經被人們瞭 如用^熱水萃取的舞茸萃取物(特 π 號公報、㈣抓麵7號公報 與特開職-誦7號公報)或含水酒精萃取 2457〇pifi 修正曰期101年8月24曰 爲第96119746號中文說明書無劃線修正本 物(特開平8-131133號公報及特開2刪_319192號公報)等 ,水或水性浴鮮取的料萃取物已經被人們暸解。用水 水性溶解取的料萃取物可以被⑽為預防癌症製 特開2〇。1_97881號公報〉、抗氧化劑(特開2。。5 22_7 1么報)、抗真菌劑(特開2〇〇4_189737號公報)以及酪氨酸 ,、α-叙粉酶的酶抑制劑(特開2〇〇〇 319192 【發明内容】 本發明的目的就是在提供一種嶄新地、更有效地促進 皮脂產生的舞茸萃取物以及含有此萃取物的組成物。 y本發明者們為解決上述課題,在進行認真地探討研究 後’發現用純_萃取的乾㈣料取物具有很強的促進 皮月曰產生效果,完成了本發明。 也就是說,本發明如下。 (1) 一種舞茸萃取物,其是使用純酒精從乾燥舞茸中 萃取得到。 (2) 在(1)中記載的舞茸萃取物中所使用的乾燥舞茸的 含水量為小於等於8重量百分比(wt%)。 (3) 在(1)或(2)中記載的舞茸萃取物中所使用的純酒精 的酒精含量為以容量計算大於等於99%。 (4) 含有(l)-(3)t任何i項中記載的含有舞茸萃取物 之促進皮脂產生的組成物。 (5) 在(4)中記載的組成物是化妝品。 (6) 在(4)中記載的組成物是醫藥品。 本發明可以有效地促進皮脂的產生,以及有效地改善 2457〇pifl 爲第96119746號中文說明書無劃線修正本 修正日期101年8月24日 由於皮脂減少而引起的皮膚的障礙、皮膚的異常和疾患的 症狀。 為讓本發明之上述和其他目的、特徵和優點能更明顯 易懂’下文特舉較佳實施例,並配合所附圖式,作詳細說 明如下。 【實施方式】 本發明是有關於一種舞茸萃取物,其是利用純酒精從 乾燥舞茸中萃取而得到。 本發明中的舞茸,是指多孔菌科、豬苓屬(Grifola)的 艮用菌’其包括舞茸(Grifola frondosa)、白舞茸(Grifola albicans)、豬令((^咐也 umbeuatus)、亞灰樹花(Grif〇ia gigantean)等。本發明的舞茸最理想的是指Grif〇la frondosa。本發明的舞茸可以是子實體或菌絲體,但最理 想的是指子實體。 本發明是以乾燥舞茸作爲被萃取的原料,而乾燥舞茸 是指t分含量為小於等於10重量百分比(Wt%)的舞茸。理 想的是指水分含量為小於等於8 wt% =含量為小於等於7wt%的舞茸。乾燥舞茸是;^ 任思的方邮Π陰乾、加熱賴 將新鮮的舞茸脫次.於〜來乾垛4) 是指呈粉末㈣乾燥it 。最理想的乾燥舞茸 本發明中的純酒精是指在旦 :=::=:想_精== 、;。的酒精,最理想的純酒精是指酒 24570pifi 修正曰期101年8月24日 爲第96丨19746獅文__劃_1£本 精含量為以容量計算大於等於99.5%的酒精。 乾燥料的純闕萃取法,是在補(乾騎茸)中添 拌之後,在常溫或加熱情況T進行—定時間的攪 加熱溫度通常是_軸以下的溫度,但在密封容; :120尸以下溫度也可。理想的萃取溫度是常溫(室溫)。 ’萃取時間沒有特別的限定,例如5分〜1〇小時之 間左右。萃取次數可以進行1〜2次。 、在進行萃取時,以乾燥舞茸為100重量份的情況下, 純,精的使用量為丨〇〇〜丨〇〇〇重量份,理想的是2〇〇〜6〇〇 重畺份,最理想的是300〜5〇〇重量份。 片萃取處理結束後’用濾紙或濾布過濾或使用離心分離 等分離手段,以獲取純酒精萃取液。 本發明中的舞茸純酒精萃取物可以呈上述的酒精萃 取液狀態。或者’純酒精萃取物也可以是使用通常的方 法’從萃取液中全面或部分的去除酒精後的萃取物。也就 是說’本發明中的舞茸純酒精萃取物可以是不含有酒精的 萃取粉末或者是含酒精量為1〜5〇wt%的萃取物。其中, 含酒精量為10〜15 wt%的萃取物因爲保存性良好,是最 理想的。純酒精萃取物的獲取量為乾燥舞茸重量的2〜 10%,可以更加肯定的是乾燥舞茸重量的3〜5%(固成分 (solid content))的量可以獲得。純酒精萃取物中含有磷脂 質(phospholipid)和植物性甾族化合物(steroid),但其含有 的有效成分尚不能確定。 本發明含有由上述萃取物之促進皮脂產生的組成物。 1379684 ' 24570pifl - 爲第96丨测6號中文說明書無劃線修正本 修正日期101年8月24日 本發明的組成物可促進皮脂產生、保持皮膚表皮的濕 潤,以賦予皮膚表皮潤澤和柔軟性,且同時還可以增強皮 膚的強度。而且,它還具有防止皮膚表皮受到紫外綫的傷 害’保護皮膚不受異物和變態反應源的入侵。因此,本發 明含有由上述萃取物之促進皮脂產生的組成物,可例如是 化妝品。 本發明的組成物是化妝品,其含有化妝品中慣用的載 體、賦形劑、添加物等,可以被作爲防止皮膚乾燥、保持 * 皮膚細腻和皮膚的柔軟性、改善皮膚的乾燥症狀等的護膚 品使用。也可以應用在清洗臉部(如洗臉霜.泡沫·膏等)、 調皮膚狀‘%用(化妝水·美容液等)、護膚用(乳液.保濕 柏專)、面膜.油.按摩化妝品、化妝打底用(粉底霜白 粉、防曬類護膚品等)、局部化妝用(唇膏·眼影膏·眼綫 等)、沐浴用(香皂·沐浴液·盆浴液等)、防曬類護膚品等、 育發·生發用(育發劑·生發液等)等化妝品領域。在這些 化妝品中,舞茸萃取物能夠有效發揮作用的使用量為如: • 用萃取物換算,則是在〇_1〜99.9 wt〇/〇這個範圍,比較理 想的疋1〜99 wt%之間。在剩餘部分中,以常用的載體、 賦形劑或是添加劑等相互調配。 本發明的萃取物’具有改善因皮脂產生的減少而引起 的皮膚P早礙或皮膚疾患的症狀。因此,本發明的萃取物也 可以是外用藥品,它包含了由上述萃取物組成的具有促進 皮脂產生作用的組成物。 本發明的萃取物可例如是外用藥品,其含有藥品中慣 1379684 24570pifl 修正日期⑼年8月24日 爲第96119746號中文說明書無劃線修正本 用的載體、賦形劑和添加物。由於皮脂的減少而弓丨 膚障礙或皮膚疾患如皮膚乾燥症,皮脂減少性皮膚炎的^ 幣狀皮膚炎,過敏性皮膚炎等。藥品的形態包括:=、’貨 懸濁液、化妝水、霜、軟膏、凝膠等。在這些外用藥:乂、 如用萃取物換算舞茸萃取物的有效量,在〇 1〜Q、^中’ wt% 之間,比較理想的是1〜99 wt%之間相調配。在剩餘*八 中,以常用的載體、賦形劑或是添加劑等相互調配。分 在化妝品或醫藥品中,常用的調配用之载體、賦形 或添加劑等,可例如是:溶劑,植物油(例如,杏仁4 = 蓖蔬油、可哥脂、椰子油、玉米油、錦籽油、亞麻介、由 撖欖油、棕櫚油、花生油、罌粟籽油、菜油、芝麻油"、豆 油、葵花籽油以及茶油等食用油)、礦油、脂肪油\液= 油、緩衝劑、防腐劑、保濕劑、螯合劑、抗氧化劑、 安定劑、乳化劑、懸浮劑(suspending agent)、凝膠劑、軟 膏基劑、坐劑基劑、滲透劑、芳香劑以及護膚劑等。 上述之溶劑,例如是水、酒精、聚乙烯二醇、丙二醇、 甘油、液體聚二曱基矽氧烷以及它們的混合物等,但又 限定於此。 ~~ +众士述之緩衝劑,例如是檸檬酸、醋酸、酒石酸、乳酸、 礤馱氫、乙二胺以及它們的混合物等,但並不限定於此。 ^上述之保属劑,例如是甘油、丙二醇、戊二醇、山梨 * 一乳酉夂尿素、13_ 丁二醇(13 butylene glyC〇 卜 13 BG)、 大豆固=以及它們的現合物,但又不限定於此。 上述之防腐劑’例如是EDTA鈉、檸檬酸以及它們 1379684 ' 24570pifl - 爲第96119746號中文說明書無劃線修正本修正日期1〇1年8月24日 的混合物等’但又不限定於此。 上述之抗氧化劑’例如是丁基化經基茴香喊 (butylated hydroxyanisole ’ BHA)、維生素 c 和其謗導體、 維生素E和其誘導體、半胱氨酸(cysteine)以及它們的混合 物等’但又不限定於此。 上述之乳化劑,例如是天然膠(例如,刺槐豆膠)、黃 蓍膠、頁原膠,天然磷脂(例如,大豆印鱗脂);聚山梨醋 80誘導體;羊毛脂;羊毛脂醇;山梨聚糖酯;甘油單酯; 籲 脂肪醇(例如’山蝓醇);脂肪酸酯(例如,三(辛酸/葵酸) 甘油醋)、類似於單硬脂酸(SE)—樣的脂肪酸的甘油三酯以 及它們的混合物,但又不限定於此。 上述之懸浮劑,例如是纖維素以及其誘導體(例如, 羧甲基纖維素 '羥乙基纖維素、羥丙纖維素、羥丙基曱基 纖維素等)、角又菜膠、刺槐豆膠、阿拉伯樹膠、黃蓍膠 (tragacanth gum)以及它們的混合物等,但又不限定於此。 上述之凝膠基劑以及增粘成分,例如是液體石蠟油、 • 聚乙烯、脂肪油、膠體矽、膠體鋁、鋅皂、甘油、丙二醇、 黃蓍膠、緩基乙烯基聚合物(carb〇xyvinyl p〇iymer)、石夕酸 鎂鋁、親水性聚合物(例如,澱粉、羧曱基纖維素、羥乙 基纖維素以及它纖維素誘導體等纖維素誘導體)、水膨潤 性親水性膠體、角叉菜膠、透明質酸鹽(例如,選擇地含 有氯化鈉的透明質酸凝膠)、藻朊酸酯(例如,藻朊酸丙二 醇醋)以及它們的混合物等,但又不限定於此。 上述之軟膏基劑,例如是蜜蠟、石蠟、酒精、鯨蠟素、 1379684 24570pi f1 爲第 96119746 修正日期101年8月24曰 99.5%) ’之後,約18個小時,在2〇t:的溫度下一邊進行 攪拌一邊進行萃取。然後,利用離心分離的方式去除殘 /查’並將所得到的上層澄清溶液,以濾紙加以過濾,接著 再通過瘵發·去除的方式除去濾液中的酒精,即可得到的 舞茸純酒精萃取物(產量為43.2g,固成分為37.2g,酒精 為 6.0g)。 〔實驗例〕舞茸的純酒精萃取物的促進皮脂產生作用 (方法)Corrected the peak of the skin on August 24, 2010. The decline 'is also the skin makeup / field eye makeup, oleic acid and broadcast report) 4 as a promotion of sebum production called ingredients has been used by people like hot water extraction of Maitake extract (Special π bulletin, (4) No. 7 Bulletin and Special Opening Ceremony - No. 7 Bulletin) or 2457 pifi of water-containing alcohol extraction, revised from January 24, 2011 to No. 96191974 Chinese manual without scribe line correction (Special Kaiping 8-131133) Bulletin and special opening 2, _319192, etc., and extracts of fresh materials taken from water or aqueous baths have been known. The water-soluble dissolved extract can be (10) specially developed for the prevention of cancer. Japanese Patent Publication No. 1978978, anti-oxidant (Specially Open 2: 5 22_7 1 reported), antifungal agent (Japanese Unexamined Patent Publication No. Hei 2 No. Hei. No. Hei. No. Hei. SUMMARY OF THE INVENTION The object of the present invention is to provide a Maitake extract which is novel and more effective in promoting the production of sebum and a composition containing the same. y The present inventors have solved the above problems. After conducting a serious investigation and research, it was found that the dry (four) extract obtained by pure extraction has a strong effect of promoting the skin growth, and the present invention has been completed. That is, the present invention is as follows. (1) A maitake The extract is extracted from dry maitake with pure alcohol. (2) The water content of dry maitake used in the maitake extract described in (1) is 8 wt% or less (wt%) (3) The alcohol content of the pure alcohol used in the maitake extracts described in (1) or (2) is 99% or more by volume. (4) Contains any of (l)-(3)t The composition containing the Maitake mushroom extract to promote the production of sebum described in item i. (5) Record in (4) (6) The composition described in (4) is a pharmaceutical product. The present invention can effectively promote the production of sebum, and effectively improve 2457 〇pifl to the Chinese manual of No. 96119746. The above-mentioned and other objects, features and advantages of the present invention will become more apparent from the above-mentioned and other objects, features and advantages of the present invention as a result of the reduction of sebum on August 24, 2011. The embodiment will be described in detail below with reference to the accompanying drawings. [Embodiment] The present invention relates to a Maitake mushroom extract obtained by extracting from dry maitake with pure alcohol. , refers to the fungi of the genus Polyporaceae and Grifola, which include Griffola frondosa, Grifola albicans, porcine ((^咐um umbeuatus), sub-ash tree flower ( Grif〇ia gigantean), etc. The most ideal of the maitake of the present invention is Grif〇la frondosa. The maitake of the present invention may be a fruiting body or a mycelium, but ideally refers to a fruiting body. The present invention is dry. Dancing The raw material to be extracted, and the dry maitake is a maitake with a t content of 10% by weight or less (Wt%). Ideally, the moisture content is 8 wt% or less = the dance content is 7 wt% or less. The dry velvet is;; 任思的方邮Π阴干,加热赖, the fresh 舞茸 is taken off. ~~干干垛4) Refers to the powder (four) drying it. The most ideal dry maitake in the invention Pure alcohol means that in the day: =::=: think _ fine ==,; the alcohol, the most ideal pure alcohol refers to the wine 24570pifi revised the flood season August 24, the 96th 丨 6 6 6 6 6 丨_ _1 £ £ The essence content is alcohol with a capacity of 99.5% or more. The pure hydrazine extraction method of the dry material is carried out in the supplement (dry velvet), and is carried out at normal temperature or in the heating condition T. The stirring temperature for the fixed time is usually the temperature below the _ axis, but in the sealing capacity; The temperature below the corpse is also acceptable. The ideal extraction temperature is room temperature (room temperature). The extraction time is not particularly limited, and is, for example, about 5 minutes to 1 hour. The number of extractions can be performed 1 to 2 times. In the case of extracting, when the dry maitake is 100 parts by weight, the amount of pure and fine is 丨〇〇~丨〇〇〇 by weight, preferably 2〇〇~6〇〇, The most desirable is 300 to 5 parts by weight. After the completion of the sheet extraction treatment, it is filtered by a filter paper or a filter cloth or a separation means such as centrifugation to obtain a pure alcohol extract. The Maitake pure alcohol extract in the present invention may be in the above-described alcohol extract state. Alternatively, the pure alcohol extract may be an extract obtained by completely or partially removing alcohol from the extract using a usual method. That is to say, the pure muslim extract of the present invention may be an extract powder containing no alcohol or an extract having an alcohol content of 1 to 5 % by weight. Among them, an extract having an alcohol content of 10 to 15% by weight is preferable because of its good preservability. The pure alcohol extract is obtained in an amount of 2 to 10% by weight of the dry maitake, and it can be more certainly obtained by the amount of 3 to 5% (solid content) of the dry maitake weight. Pure alcohol extracts contain phospholipids and phytosteroids, but the active ingredients they contain are not yet certain. The present invention contains a composition which promotes sebum production by the above extract. 1379684 ' 24570pifl - For the 96th test No. 6 Chinese manual without a slash correction This correction date is August 24, 2011. The composition of the invention promotes sebum production and keeps the skin epidermis moist, giving the skin a moisturizing and soft skin. At the same time, it can also enhance the strength of the skin. Moreover, it also protects the epidermis from ultraviolet rays. Protects the skin from foreign bodies and allergic sources. Accordingly, the present invention contains a composition which promotes sebum production by the above extract, and may be, for example, a cosmetic. The composition of the present invention is a cosmetic containing a carrier, an excipient, an additive, and the like which are conventionally used in cosmetics, and can be used as a skin care agent for preventing dryness of the skin, keeping the skin delicate and the skin soft, improving the dryness of the skin, and the like. Product use. It can also be applied to cleansing the face (such as face cream, foam, cream, etc.), skin type '% (makeup, beauty liquid, etc.), skin care (lotion, moisturizing cypress), mask, oil, massage, Make-up base (powder cream, sunscreen lotion, etc.), topical make-up (lipstick, eye shadow, eyeliner, etc.), bath (soap, body wash, bath, etc.), sunscreen lotion, etc. · Cosmetics such as hair growth (hair growth, hair growth, etc.). Among these cosmetics, the amount of maitake extract that can be effectively used is as follows: • In the range of 〇_1~99.9 wt〇/〇, it is ideally 疋1 to 99 wt%. between. In the remainder, the carriers, excipients or additives are used in combination with each other. The extract ' of the present invention has symptoms of improving skin P early damage or skin diseases caused by a decrease in sebum production. Therefore, the extract of the present invention may also be a pharmaceutical for external use, which comprises a composition composed of the above extract and having a function of promoting sebum production. The extract of the present invention may, for example, be a pharmaceutical for external use, which contains a carrier, an excipient and an additive which are conventionally used in the Chinese Patent Specification No. 1379684, 24570 pifl, August 24, 1989. Due to the reduction of sebum, bowel skin disorder or skin disorders such as dry skin, sebaceous dermatitis, anaesthetic dermatitis, etc. The form of the drug includes: =, 'storage suspension, lotion, cream, ointment, gel, and the like. In these external preparations: 乂, if the extract is used to convert the effective amount of Maitake extract, between 〇 1~Q, ^' wt%, it is desirable to mix between 1 and 99 wt%. In the remaining *8, the commonly used carriers, excipients or additives are mutually formulated. In cosmetics or pharmaceuticals, commonly used carriers, shaping or additives, etc., can be, for example, solvents, vegetable oils (for example, almond 4 = 蓖 vegetable oil, cocoa butter, coconut oil, corn oil, brocade Seed oil, flaxseed, edible oil from eucalyptus oil, palm oil, peanut oil, poppy seed oil, vegetable oil, sesame oil, soybean oil, sunflower oil and tea oil, mineral oil, fatty oil, liquid = oil, buffer Agents, preservatives, humectants, chelating agents, antioxidants, stabilizers, emulsifiers, suspending agents, gels, ointment bases, sachet bases, penetrants, fragrances, and skin care agents. The above solvent is, for example, water, alcohol, polyethylene glycol, propylene glycol, glycerin, liquid polydidecyloxyne, and a mixture thereof, but is also limited thereto. The buffer of the present invention is, for example, citric acid, acetic acid, tartaric acid, lactic acid, hydrazine hydrogen, ethylenediamine, or a mixture thereof, but is not limited thereto. ^ The above-mentioned carrier, such as glycerin, propylene glycol, pentanediol, sorbitol * chylo urea, 13 - butane diol (13 butylene gly C 〇 13 BG), soy solid = and their present compounds, but It is not limited to this. The above-mentioned preservatives' are, for example, sodium EDTA, citric acid, and their 1379684 '24570pifl - are the Chinese manual of No. 96119746, and the mixture is not slashed, and the correction date is August 24, 2011, etc., but is not limited thereto. The above antioxidants are, for example, butylated hydroxyanisole 'BHA, vitamin C and its quinone conductor, vitamin E and its inducer, cysteine and mixtures thereof, but It is not limited to this. The above emulsifiers are, for example, natural gums (for example, locust bean gum), tragacanth, sheet gum, natural phospholipids (for example, soybean squamosa); polysorbate 80 inducer; lanolin; lanolin alcohol; A sorbitan ester; a monoglyceride; a fatty alcohol (eg, 'behenyl alcohol); a fatty acid ester (eg, tris(octanoic acid/kuric acid) glycerol vinegar), similar to a monostearic acid (SE)-like fatty acid Triglycerides and mixtures thereof, but are not limited thereto. The above suspending agent is, for example, cellulose and an inducer thereof (for example, carboxymethyl cellulose 'hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl fluorenyl cellulose, etc.), horn gum, locust bean Gum, gum arabic, tragacanth gum, and mixtures thereof, but are not limited thereto. The above gel base and tackifying component are, for example, liquid paraffin oil, polyethylene, fatty oil, colloidal enamel, colloidal aluminum, zinc soap, glycerin, propylene glycol, tragacanth, and styrene vinyl polymer (carb 〇). Xyvinyl p〇iymer), magnesium aluminum alumite, hydrophilic polymer (for example, cellulose, carboxyethyl cellulose, hydroxyethyl cellulose, and cellulose inducer such as cellulose inducer), water swellable hydrophilicity Colloids, carrageenan, hyaluronic acid salts (for example, hyaluronic acid gels optionally containing sodium chloride), alginic acid esters (eg, alginic acid propylene glycol vinegar), and mixtures thereof, etc., but not Limited to this. The above ointment bases, for example, beeswax, paraffin, alcohol, cetacein, 1379684 24570pi f1 for the 96119746 revision date August 24, 2011, 99.5%) 'after about 18 hours, at 2〇t: The extraction was carried out while stirring at a temperature. Then, the residual/checking method is removed by centrifugation, and the obtained supernatant clear solution is filtered with a filter paper, and then the alcohol in the filtrate is removed by means of bursting and removing, thereby obtaining the pure gynosolic alcohol extract. (production: 43.2 g, solid content: 37.2 g, alcohol: 6.0 g). [Experimental example] The effect of pure alcohol extract of Maitake mushroom on promoting sebum production (Method)

1. In vitro實驗法 U豚鼠皮脂腺細胞的培養方法 1-M豚鼠皮脂腺細胞的分離 將雄性金色豚鼠(5周齡,從日本SLC公司購入)的左 耳及右耳的耳殼部切除’並浸泡在添加青黴素和硫酸鏈黴 素的 DMEM (Dulbecco’s modified Eagle’s medium)培養液 (Invitrogen公司生産)中,且於4 °C下放置約1小時。然 後,利用磷酸緩衝液(PBS(-))洗淨。接著,剔除耳殼部周 圍的毛,將耳殼部切成5x5 mm2的碎片,並在2.4單位/ml 的Dispase溶液(合同酒精公司生産)於4 °C下靜置13.5小 時。利用Dispase溶液處理後’用録子將耳殼部的表皮剝 離,把帶有皮脂腺的真皮浸泡在Sebocyte growth(SG)培養 液[6%(v/v)小牛血清(Nichirei Bioscience 公司生産)/2%(v/v) 人血清(ICN Biomedical LTD 公司生産 /〇.68mM L-Glutamine/100Units/ml 青黴素和 l〇〇pg/ml 硫酸鏈黴素 /DMEM/F-12]中,在顯微鏡下分離皮脂腺細胞。 11 1379684 24570pi f1 修正日期101年8月24日 爲第96119746號中文說明書無劃線修正本 1-1-2豚鼠皮脂腺細胞的組織片培養 將小鼠3T3細胞(購自理化研開發銀行)用絲裂黴素處 理4小時後,將細胞以1x103 cells/cm2的細胞數播種在-60 mm培養孤中,培養成單細胞層,作爲培養豚鼠皮脂腺 細胞的支持細胞層用。用鑷子將分離出的皮脂腺放在支持 層細胞上與其接觸’在37°C ’5% C〇2的條件下進行培養, 直至細胞增至接近密集程度。細胞培養液使用添加EGF (10ng/ml)的SGmedium ’大約2日左右更換培養液。 卜1-3豚鼠皮脂腺細胞的繼代培養鲁 將支持細胞層的小鼠3T3細胞用〇.〇2〇/0(w/v;) EDTA/PBS(·)溶液去除,之後,把增殖生長成組織片的豚 鼠皮脂腺細胞用〇.25%(w/v)胰蛋白酶/〇.〇2%(w/v) EDTA/PBS(-)溶液使其剝離,進行繼代培養。另外,全部 實驗中使用的繼代細胞均不超過3代。 1-2處理方法 將脉鼠皮脂腺細胞加入至至35 mm培養皿後的第二 天,在添加或不添加騰島素(10 nM)(Sigma-Aldrich公司生 . 産)的情況下,使用含有實施例1中得到的舞茸萃取物 (100、200以及400 pg/ml)和含有巴西蘑菇萃取物(1〇〇、2〇〇 以及400 pg/ml)的培養液[6%小牛血清/2%人血清/0.68 mML-榖氨酸/l〇〇units/ml青黴素G/100pg/ml硫酸鏈黴 素/DMEM/F-12]對細胞進行處理。3天後,再進行同樣的 處理,接著再繼續培養3天。整個實驗使用的細胞繼代培 養均不超過3代。1. In vitro method U guinea pig sebaceous gland cell culture method 1-M guinea pig sebaceous gland cell isolation Male golden guinea pig (5 weeks old, purchased from Japan SLC company) the ear and right ear of the ear shell was removed 'and soaked In a DMEM (Dulbecco's modified Eagle's medium) culture solution (manufactured by Invitrogen Co., Ltd.) to which penicillin and streptomycin sulfate were added, and left at 4 ° C for about 1 hour. Then, it was washed with a phosphate buffer (PBS(-)). Next, the hair around the ear shell was removed, and the ear shell was cut into pieces of 5 x 5 mm 2 and allowed to stand at 4 ° C for 13.5 hours in a 2.4 unit/ml Dispase solution (manufactured by Contract Alcohol Co., Ltd.). After treatment with Dispase solution, the epidermis of the ear shell was peeled off by the recording, and the dermis with sebaceous glands was immersed in Sebocyte growth (SG) medium [6% (v/v) calf serum (manufactured by Nichirei Bioscience) / 2% (v/v) human serum (produced by ICN Biomedical LTD / 68 68 mM L-Glutamine / 100 Units / ml penicillin and l 〇〇 pg / ml streptomycin / DMEM / F-12) under the microscope Separation of sebaceous gland cells. 11 1379684 24570pi f1 Revision date August 24, 2011 is the Chinese manual No. 96191974. No slash correction. 1-1-2 Tissues of guinea pig sebaceous gland cells. Mouse 3T3 cells (purchased from Physicochemical Research and Development) Bank) After treatment with mitomycin for 4 hours, the cells were seeded at -10 mm cells in a cell size of 1×103 cells/cm 2 and cultured into a monolayer as a supporting cell layer for culturing guinea pig sebocytes. The isolated sebaceous glands were placed on the support layer cells and cultured at 37 ° C '5% C 〇 2 until the cells were increased to near intensity. The cell culture medium was supplemented with EGF (10 ng/ml). SGmedium 'Change culture around 2 days Subculture of 1-3 guinea pig sebaceous gland cells The mouse 3T3 cells supporting the cell layer were removed with 〇.〇2〇/0(w/v;) EDTA/PBS(·) solution, and then proliferated. The guinea pig sebaceous gland cells grown into tissue pieces were exfoliated with 〇.25% (w/v) trypsin/〇.〇2% (w/v) EDTA/PBS(-) solution, and subcultured. None of the subcultured cells used in the experiment were more than 3 generations. 1-2 Treatment method The day after the addition of the mouse sebocytes to the 35 mm culture dish, with or without the addition of temsin (10 nM) (Sigma) -In the case of Aldrich, the maitake extract (100, 200 and 400 pg/ml) obtained in Example 1 and the extract containing Brazilian mushrooms (1〇〇, 2〇〇 and 400 pg) were used. /ml) of culture medium [6% calf serum/2% human serum / 0.68 mML-valine / l〇〇units / ml penicillin G / 100pg / ml streptomycin / DMEM / F-12] on the cells The treatment was carried out. After 3 days, the same treatment was carried out, and then the culture was continued for another 3 days. The cells used in the whole experiment were subcultured for no more than 3 passages.

S 12 1379684 2457〇pifl 修正日期101年8月24曰 爲第96119746號中文說明書無劃線修正本 1-3 Oil red Ο 染色法 含有0.3% oil red 0(Sigma-Aldrich公司生産)的異丙 醇(isopiOpanol)溶液和雙蒸水以3 : 2(v : v)的比例加以混 合後,放置在密封式超音波細胞粉碎裝置裏進行15分鐘 超音波處理。然後在室溫裏放置1〇分鐘,過濾。將過滤 後的上層澄清溶液之oil red 〇作爲染色液使用。用pBs(_) 將細胞清洗乾淨後,添加固定液[4〇/0三聚甲酸 (Paraformaldehyde)/PBS(-)]在室溫裏固定1個小時。固定 後,用热顧水把細胞清洗乾淨,添加oil red 〇染色液,在 37 C下進行15分鐘染色。染色後,把細胞用流水清洗乾 淨’用光學顯微鏡觀察脂肪滴的形成。並且,在光學顯微 鏡下將經過oil redO染色的細胞拍成數位晝像,用解析畫S 12 1379684 2457〇pifl Revised date August 24, 2011 is No. 96119746 Chinese manual No scribe correction 1-3 Oil red 染色 Dyeing method contains 0.3% oil red 0 (Sigma-Aldrich) isopropanol The (isopiOpanol) solution and the double distilled water were mixed at a ratio of 3:2 (v:v), and placed in a sealed ultrasonic cell pulverizing apparatus for ultrasonic treatment for 15 minutes. It was then placed at room temperature for 1 minute and filtered. The oil red 〇 of the filtered supernatant solution was used as a staining solution. After the cells were washed with pBs(_), a fixing solution [4〇/0 polyformic acid (Paraformaldehyde)/PBS(-)] was added and fixed at room temperature for 1 hour. After fixing, the cells were washed with hot water, and the oil red sputum staining solution was added and stained at 37 C for 15 minutes. After the staining, the cells were washed with running water to clean the formation of fat droplets by an optical microscope. Also, the cells stained with oil redO were photographed as digital images under optical microscopy.

像•定量化軟體Lumina Vision Ver2.2.2(三谷商事(MITANI CORPORATION)公司製造)在各處理中不同的3個地方的 細胞内積蓄的脂肪滴的比例定量,其定量以晝像單位來表 示。 φ 1-4細胞内皮脂量的定量 1) 樣品調製法 經藥物處理後的細胞用PBS(·)清洗2次,用0.25%胰 蛋白酶(trypsin)/0.02% EDTA/PBS(-)的溶液將其回收,冰 凍回收到的細胞懸浮液,進行超聲波處理將細胞粉碎。 2) 甘油三脂量的測定法 使用TGII (Roche · Diagnostics公司)測定皮脂的主要 成分甘油三脂(TGs)的量,也就是在上記”1)”的細胞粉碎樣 13 1379684 24570pifl 爲第96119746號中文說明書無劃線修正本 修正日期101年8月24日 品裏添加處理液 1 [1.65 IU/ml glycerolkinase/6 IU/ml glycerol-3 -phosphate oxydase/catalase/2.95 μιηοΐ/ml disodium adenosin-5’-triphosphate,trihydrate (ATP)yO.65 μιηοΐ/mlsodium N-(3 , 5-dimeriioxyphenyl)-N’-succinylethylenediamine(DOSE)], 在37 °C下讓其反應10分鐘,去除游離型甘油。之後, 立刻添加處理液 2 [0.55 IU/ml lipoproteinlipase/peroxidase/0.65 μιηοΐ/ml 4-aminoantipyrin (4-AA)],再讓其在37。。下反應10分鐘。反應終止後, 在590 nm測定吸光度。同樣的通過triolein標準液(0.6 mg/ml)的吸光度計算出TGs的量。並且,用 3,5-diaminobenzoic acid dihydrochloride (DΑΒΑ)法測定出 細胞粉碎樣品中的DNA的含量,計算出1 gg DNA當中 的TGs的含量。 2. In vivo實驗法 在出生3周的雄性豚鼠(從日本SLC公司購入)(處理 組,每組n=l)的耳殼部(左耳)塗抹含有舞茸萃取物和含有 巴西蘑兹萃取物的溶液(95%ethanol/5% glycerol),每天1 次,每次50 μ卜同樣的,在同一豚鼠的右耳處塗抹了不 含有舞茸萃取物和含有巴西蘑菇萃取物的溶液(95% ethanol/5%glycerol)(對照組,每組η=1)。2星期後,將豚 氣的耳殼部做成康結切片’進行oil recj 〇染色。在光學顯 微鏡下,將經過oil redO染色的耳殼部的組織切片拍 位畫像,用畫像解析·定量化軟體Lum二== 1379684 24570pifl 修正日期101年8月24日 爲第96119746號中文說明書無劃線修正本 滴的比例定量’其定量以畫像單位來表示。 3.統計處理 用Fisher多變量分散分析法實施各個處理間顯著性 差異的檢定。 (結果) 1. In vitro 實驗For example, the quantitative software Lumina Vision Ver2.2.2 (manufactured by MITANI CORPORATION) quantifies the proportion of fat droplets accumulated in cells in three different places in each treatment, and the quantification is expressed in units of artifacts. Quantification of endothelial lipid content of φ 1-4 cells 1) Sample preparation The drug-treated cells were washed twice with PBS (·), and a solution of 0.25% trypsin/0.02% EDTA/PBS(-) The recovered, frozen recovered cell suspension is subjected to ultrasonic treatment to pulverize the cells. 2) Determination of the amount of triglyceride using TGII (Roche Diagnostics) to measure the amount of triglyceride (TGs), the main component of sebum, that is, the cell pulverization sample in the above "1)" 13 1379684 24570pifl is No. 96119746 Chinese manual no slash correction This correction date is added to the product on August 24, 101. [1.65 IU/ml glycerolkinase/6 IU/ml glycerol-3 -phosphate oxydase/catalase/2.95 μιηοΐ/ml disodium adenosin-5' -triphosphate, trihydrate (ATP) yO.65 μιηοΐ/mlsodium N-(3 , 5-dimeriioxyphenyl)-N'-succinylethylenediamine (DOSE)], allowed to react at 37 ° C for 10 minutes to remove free glycerol. Immediately thereafter, add the treatment solution 2 [0.55 IU/ml lipoproteinlipase/peroxidase/0.65 μιηοΐ/ml 4-aminoantipyrin (4-AA)], and let it be at 37. . The reaction was carried out for 10 minutes. After the reaction was terminated, the absorbance was measured at 590 nm. The amount of TGs was calculated by the absorbance of the triolein standard solution (0.6 mg/ml). Further, the content of DNA in the pulverized sample was measured by the 3,5-diaminobenzoic acid dihydrochloride (DΑΒΑ) method, and the content of TGs in 1 gg DNA was calculated. 2. In vivo experimental method The male guinea pig (purchased from SLC, Japan) (the treatment group, n=l in each group) of the ear shell (left ear) was coated with Maitake extract and contains Brazilian mushroom extract. Solution (95% ethanol / 5% glycerol), once a day, 50 μg each time, the same guinea pig's right ear was coated with a solution containing no Maitake extract and containing Brazilian mushroom extract (95 % ethanol / 5% glycerol) (control group, each group η = 1). After 2 weeks, the ear shell portion of the dolphins was made into a section of 'Kangjie' and subjected to oil recj 〇 staining. Under the optical microscope, the tissue slice of the ear shell portion stained with oil redO is photographed, and the image is analyzed and quantified. Lum II = 1379684 24570pifl Corrected date August 24, 2011 is No. 96119746 The line corrects the proportion of the drop quantitative 'the quantification is expressed in units of portraits. 3. Statistical processing The Fisher multivariate dispersion analysis method was used to perform the verification of significant differences between treatments. (Result) 1. In vitro experiment

(1) 未經胰島素處理的細胞群(低分化型),舞茸萃取物 促進了細胞内脂肪滴的形成(圖1B,400 ng/ml;和圖1A 攀對比)。同時,也證實了舞茸萃取物的促進脂肪滴形成作 用是一種濃度依存性關係(圖2)。另一方面,巴西蘑菇則 很微弱地促進了細胞内脂肪滴的形成(圖lc,4〇〇^g/ml ; 和圖1A及圖2對比),和舞茸萃取物相比其促進作用明顯 地比較弱(ρ<0.001)。 (2) 經過胰島素處理的細胞(分化型),舞茸萃取物同樣 以濃度依存性地方式促進了細胞内脂肪滴的形成(圖1Ε ; 和圖ID及圖2對比)。另一方面,在相同條件下的巴西磨 • 料取物雖然也促進了細胞内脂肪滴的形成(圖1F;和圖 1D及圖2對比)’但和舞茸萃取物相比其促進作用明顯地 比較弱(p<0.001)。 (3) 未經胰島素處理的細胞群,舞茸萃取物濃度依存 性地增加了細胞内甘油三脂的含量(圖3)。但是,在相同 ,件下的巴西蘑菇萃取物沒有改變細胞内甘油三脂的含 里(圖3)。另一方面,經過胰島素處理的細胞,舞茸萃取 物同樣濃度依存性地增加了細胞内甘油三脂的含量(圖 15 1379684 24570pifl 爲第96119746號中文說明書無劃線修正本 修正曰期101年8月24曰 3)。而巴西磨兹萃取物雖然也增加了細胞内甘油三脂的含 量’但同樣在400 pg/mi的濃度下,和舞茸萃取物相比’ 其增加的甘油三脂的含量則明顯的比較低(圖3)。 2· In vivo 實驗 (1)下表是勝鼠在舞茸萃取物及巴西蘑菇萃取物處理 前後的體重變化。 舞茸萃取物 巴西蘑菇萃取物 濃度 — 1% 2% 4% 1% 2% 4% 扁號 豚鼠1 豚鼠2 豚鼠3 豚鼠4 豚鼠5 豚鼠6 處埋前(a) 42.3 g 47.9 g 45.2 g 47.3 g 46.8 g 46.3 g 處理後(b) 84.1 g 92.0 g 81.0g 92.0 g 85.0 g 86.0 g ^*jt(b-a) 41.8 g 44.1 g 35.8 g 44.7 g 38.2 g 39.7 g (2) 舞茸萃取物在1%、2%以及4%的濃度下,分別促 進了皮脂腺組織的皮脂蓄積量1.6倍、3倍以及1.3倍(圖 4以及圖6A)。 (3) 1%的巴西蘑菇萃取物抑制了皮脂腺組織的皮脂蓄 積量’而其他濃度(2%以及4%)則沒有觀察到皮質蓄積量 有顯著的變化(圖5以及圖6A)。 (討論) 在in vivo以及in vitro實驗中,明顯地顯示出舞茸萃 取物具有促進皮脂產生的作用。同時,舞茸萃取物的促進 作用明顯較巴西蘑菇的促進作用強的事實也得以證實。也 就是說,舞茸萃取物是強有力地促進皮脂產生物質,不僅 對乾燥皮膚的保養,對減輕皮膚乾燥症等因爲皮脂腺功能 下降而引起的皮膚疾患的症狀都有一定的效果。 16 1379684 - 24570pi f1 修正日期101年8月24日 爲第96119746號中文說明書無劃線修正本 〔實施例2〕 舞茸的純酒精萃取物的甘油三脂(TGs)特異性產生的 促進作用 (方法) 1. 豚鼠皮脂腺細胞的培養 將豚鼠皮脂腺細胞以2.35x104 cells/cm2的細胞數播 種在35mm培養皿中,次日將實施例1中得到的舞茸萃取 物(100、200以及400 pg/ml)單獨或和胰島素(1〇 nM)加入 ® 脂腺細胞培養液(SBCM)[DMEM/F-12/6°/〇(v/v)小牛血清 /2%(v/v)人企清/0.68 mM L-榖氨酸/100 units/ml 青黴素 G/100 pg/ml硫酸鏈黴素]中培養3曰。3曰後,用新調製 的同樣舞茸萃取物或和膜島素(10 nM)加入脂腺細胞培養 液(SBCM)中再培養3日。對照組是用不含舞茸萃取物和 胰島素的培養液(SBCM)培養的脂腺細胞。 2. 皮脂組成分析 將用含有或不含舞茸萃取物的培養液(SBCM)培養的 • 脂腺細胞用PBS(_)洗淨2次,用〇.25%(w/v)胰蛋白酶 /0.02%(w/v) EDTA/PBS (-)溶液回收細胞。將回收的細胞 懸浮液置於冰水中’用密閉式超音波細胞破裳置 (Bioruptor ’ COSMO . Bio公司製造)進行超音波處理5分 鐘(200W,6秒),製成皮脂組成分析的材料。將此材料移 至脫脂Spitz管’加入氣仿:甲醇(2 :丨;v : v)的溶液來 萃取脂質《將萃取的脂質用自動薄層色譜分析儀器(TLc MATRON Co·製造)進行分析。分析方法為,將萃 Ο 17 1379684 24570pifl 爲第96119746號中文說明書無劃線修正本 修正日期101年8月24日 質點在棒狀薄層後,加入氣仿:曱醇(35 : 35)的溶液進行 1次展開(1.5 cm);用苯:氣仿:醋酸(50 : 20 : 0.7)進行2 次展開(8 cm);進一步用己烷:苯(35: 35)進行3次展開(U cm)。然後,將此在棒狀薄層上分離出來的脂質,用氫火 焰離子化檢測器(Flame Ionization Detector ’ HD)在室溫下 以30秒/棒的速度直接檢測出來。 另外,對各脂質的組成用已知量的標準脂質對照下用 液相色譜儀進行分析,如3-棕搁酸甘油酯(對應圖7的 TG);棕櫚酸甘油酯(對應圖7的FFA);膽固醇(對應圖7 的Cho);棕橺酸甘油酯膽固醇(對應圖7的ChoE)(Do〇san Serdary Research Laboratories公司生產);以及軟脂酸(對 應圖7的Wax E)(Nu-Chek PreP Inc生產)。另外,用醋酸 膽固醇(2 pg)(Doosan Serdary Research Laboratories 公司生 產)作爲内部標準品的峰值面積對各個脂質進行定量計 算。 (結果) 根據皮質組成分析的結果,證明舞茸萃取物(100、200 以及400 pg/ml)首先濃度依存性地增加了皮質成分中的甘 油三脂的含量(圖7)。另外,舞茸萃取物在400 pg/ml濃度 下,增加了膽固醇酯(ChoE)以及游離脂肪酸(FFA)的含 量。它們的含量在全脂量中分別佔2.2%和5.3%,與佔 81.5%的甘油三脂相比,明顯含量要低。 〔實施例2〕 以下’是含有舞茸萃取物護膚霜(作爲美容用品)的配 1379684(1) Cellular groups (low-differentiated) that were not treated with insulin, Maitake extract promoted the formation of intracellular fat droplets (Fig. 1B, 400 ng/ml; compared with Fig. 1A). At the same time, it was confirmed that the promotion of fat droplet formation by Maitake extract is a concentration-dependent relationship (Fig. 2). On the other hand, Brazilian mushrooms faintly promoted the formation of intracellular fat droplets (Fig. lc, 4〇〇^g/ml; compared with Fig. 1A and Fig. 2), and its promotion effect was significantly higher than that of Maitake extract. The ground is weak (ρ < 0.001). (2) Insulin-treated cells (differentiated), Maitake extract also promoted the formation of intracellular fat droplets in a concentration-dependent manner (Fig. 1; compared with Fig. ID and Fig. 2). On the other hand, the Brazilian mill extract under the same conditions promoted the formation of intracellular fat droplets (Fig. 1F; compared with Fig. 1D and Fig. 2) but it was significantly more effective than Maitake extract. The ground is weak (p < 0.001). (3) The concentration of Maitake extract increased the amount of intracellular triglyceride in the cell population without insulin treatment (Fig. 3). However, under the same conditions, the Brazilian mushroom extract did not alter the intracellular triglyceride content (Figure 3). On the other hand, the insulin-treated cells, the concentration of Maitake extract, increased the intracellular triglyceride content in the same concentration (Fig. 15 1379684 24570pifl is No. 96119746 Chinese manual no underline correction this revision period 101 years 8 Month 24曰3). However, the Brazilian mill extract also increased the intracellular triglyceride content, but at the concentration of 400 pg/mi, the increased triglyceride content was significantly lower than that of Maitake extract. (image 3). 2· In vivo Experiment (1) The following table shows the changes in body weight before and after treatment with Maitake Extract and Brazilian Mushroom Extract. Maitake Extract Brazil Mushroom Extract Concentration - 1% 2% 4% 1% 2% 4% Flat Guinea Pig 1 Guinea Pig 2 Guinea Pig 3 Guinea Pig 4 Guinea Pig 5 Guinea Pig 6 Pre-buried (a) 42.3 g 47.9 g 45.2 g 47.3 g 46.8 g 46.3 g after treatment (b) 84.1 g 92.0 g 81.0 g 92.0 g 85.0 g 86.0 g ^*jt (ba) 41.8 g 44.1 g 35.8 g 44.7 g 38.2 g 39.7 g (2) Maitake extract at 1%, At the concentrations of 2% and 4%, the sebum accumulation in the sebaceous gland tissue was promoted by 1.6 times, 3 times, and 1.3 times, respectively (Fig. 4 and Fig. 6A). (3) 1% of the Brazilian mushroom extract inhibited sebum accumulation in sebaceous gland tissue while other concentrations (2% and 4%) showed no significant change in cortical accumulation (Fig. 5 and Fig. 6A). (Discussion) In in vivo and in vitro experiments, it was apparent that the Maitake extract has an effect of promoting sebum production. At the same time, the fact that the promotion of Maitake extract is significantly stronger than that of Brazilian mushrooms has been confirmed. In other words, the maitake extract is a substance that strongly promotes the production of sebum, and has a certain effect not only on the maintenance of dry skin, but also on the symptoms of skin diseases caused by a decrease in sebaceous gland function such as skin dryness. 16 1379684 - 24570pi f1 Revision date August 24, 2011 is the Chinese manual No. 96191974 No-line correction [Example 2] The promotion of triglyceride (TGs)-specific production of pure alcohol extract of Maitake ( Method) 1. Culture of guinea pig sebaceous gland cells The guinea pig sebaceous gland cells were seeded in a 35 mm culture dish at a cell number of 2.35 x 104 cells/cm 2 , and the maitake extract obtained in Example 1 (100, 200, and 400 pg/ Ml) alone or in combination with insulin (1〇nM)® adipose cell culture medium (SBCM) [DMEM/F-12/6°/〇(v/v) calf serum/2% (v/v) /0.68 mM L-valine / 100 units / ml penicillin G / 100 pg / ml streptomycin sulfate culture medium 3 曰. After 3 weeks, the same preparation of the same Maitake extract or the addition of mesin (10 nM) to the lipocyte culture medium (SBCM) for another 3 days. The control group was a lipocyte cultured in a culture medium (SBCM) containing no Maitake extract and insulin. 2. Analysis of sebum composition • The adipose gland cells cultured with broth (SBCM) containing or without Maitake extract were washed twice with PBS (_) for 25.25% (w/v) trypsin/0.02 %(w/v) EDTA/PBS (-) solution was used to recover cells. The recovered cell suspension was placed in ice water and subjected to ultrasonic treatment for 5 minutes (200 W, 6 seconds) using a sealed ultrasonic cell (Bioruptor's COSMO. Bio Inc.) to prepare a sebum composition analysis material. The material was transferred to a degreased Spitz tube and a solution of methanol (2: hydrazine; v: v) was added to extract the lipid. The extracted lipid was analyzed by an automatic thin layer chromatography instrument (manufactured by TLc MATRON Co.). The analysis method is that the extraction method 17 1379684 24570pifl is the Chinese manual of No. 96191974. There is no slash correction. The correction date is August 24, 2011. After the mass point is in the thin layer of the rod, a solution of oxime: sterol (35: 35) is added. 1 development (1.5 cm); 2 developments (8 cm) with benzene:formaldehyde:acetic acid (50:20:0.7); further expansion with hexane:benzene (35:35) (U cm ). Then, the lipid separated on the rod-shaped thin layer was directly detected by a Flame Ionization Detector's HD at room temperature at a rate of 30 sec/rod. In addition, the composition of each lipid was analyzed by a liquid chromatograph using a known amount of a standard lipid control, such as 3-palmitoglyceride (corresponding to TG of Figure 7); palmitate (corresponding to FFA of Figure 7) Cholesterol (corresponding to Cho of Fig. 7); palm citrate cholesterol (corresponding to ChoE of Fig. 7) (produced by Do〇san Serdary Research Laboratories); and palmitic acid (corresponding to Wax E of Fig. 7) (Nu- Produced by Chek PreP Inc.) Further, each lipid was quantitatively calculated using cholesteric acetate (2 pg) (manufactured by Doosan Serdary Research Laboratories) as the peak area of the internal standard. (Results) Based on the results of the cortical composition analysis, it was confirmed that the Maitake extract (100, 200, and 400 pg/ml) firstly increased the content of the triglyceride in the cortical component in a concentration-dependent manner (Fig. 7). In addition, Maitake extract increased the content of cholesterol ester (ChoE) and free fatty acid (FFA) at a concentration of 400 pg/ml. Their content is 2.2% and 5.3% in the total fat content, respectively, and is significantly lower than the 81.5% triglyceride. [Example 2] The following is a product containing a Maitake mushroom skin cream (as a beauty product) 1379684

24570pifl 爲第96119746號中文說明書無劃線修正本 修正日期101年8月24曰 方。 成分名 調配量(wt%) 舞茸萃取物 2.0 橄欖油 10.0 甘油三(辛酸/葵酸)酯 10.0 維生素E 1.0 精製水 77.0 共計 100.0 〔實施例3〕 以下’疋含有舞茸萃取物護膚霜(作爲醫藥品)的配 方。 成分名 配合量(wt%) 舞茸萃取物 10.0 撖欖油 10.0 甘油三(辛酸/葵酸)酉旨 10.0 維生素E 10 精製水 69.0 共計 100.0 〔實施例4〕 舞茸萃取物對乾皮症患者的作 用效果 如實施例2所示,用含有2wt%舞茸萃取物的護膚霜 對乾皮症患者進行試驗性治療 ’以觀察其效果。 試驗方法 試驗對象:本試驗對住在老人保健設施(G〇〇dWell) 19 1379684 24570pifl 爲第96丨19746卿文翻書_讎正本 修ΪΕ日期1〇1年8月24曰 内的患有乾皮症,脫屑12名患者(76-97歲,其中男女各6 名)。 實施期間:2〇〇6年12月〜2007年1月 匕=法:以脫屑(皮膚的角質層脫落的症狀)為基準分爲 段(3 ··重症;2 :中症;1 :輕症)對被試驗者的皮膚進 订分級評價後’在被試驗者的皮膚上塗抹舞茸萃取物的護24570pifl is the Chinese manual of No. 96119746 without a slash correction. The date of amendment is August 24, 2011. Formulation amount (wt%) Maitake extract 2.0 Olive oil 10.0 Triglyceride (octanoic acid / sunflower acid) ester 10.0 Vitamin E 1.0 Refined water 77.0 Total 100.0 [Example 3] The following '疋 contains Maitake extract skin cream ( Formulated as a pharmaceutical). Ingredient name (wt%) Maitake extract 10.0 撖 油 10.0 glycerol tris(octanoic acid / sunflower acid) 酉 10.0 Vitamin E 10 purified water 69.0 total 100.0 [Example 4] Maitake extract for patients with dry skin The effect of the action was as shown in Example 2, and a dry skin disease patient was subjected to experimental treatment with a skin cream containing 2% by weight of Maitake extract to observe the effect. Test method Test subjects: This test is for the elderly living facilities (G〇〇dWell) 19 1379684 24570pifl for the 96th 丨 丨 6 6 6 丨 丨 雠 雠 雠 雠 雠 雠 雠 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有 患有Skin disease, 12 patients with desquamation (76-97 years old, including 6 males and 6 females). During the implementation period: December 2, 2007 to January 2007 匕 = method: divided into paragraphs based on desquamation (symptoms of exfoliation of the skin) (3 · · severe cases; 2: moderate symptoms; 1: light After the evaluation of the skin of the test subject, the application of the velvet extract on the skin of the testee

膚霜。塗抹部位包括:右下腕、左下腕、右下腿、左下腿, 並在此部位上進行評價。 結果 果顯不被試驗者從塗抹試驗開始1周後的皮 ==靖,度(3:重症;2:中症;ι: 外, β斷#度.0’則表示Skin cream. The application site includes: a right lower wrist, a lower left wrist, a lower right leg, and a lower left leg, and is evaluated on this portion. Results The skin was not tested by the tester 1 week after the start of the smear test == Jing, degree (3: severe; 2: middle disease; ι: outside, β break # degree. 0' means

被試驗者1 診察·塗抹曰 2006/12/4 右下腕 左下腕 右下腿 左下腿 2006/12/6 2 1 2 2 2006/12/8 1 1 1 1 2006/12/11 1 1 1 1 1 0 1 1 被試驗者2 診察·塗抹曰 2007/1/17 右下婉 1 左下腕 右下腿 左下腿 2007/1/19 1 2 1 2007/1/22 1 1 1 1 2006/12/11 0 0 1 1 0 0 1 1Subject 1 Examination and application 曰2006/12/4 Right lower wrist Left lower wrist Right lower leg Left lower leg 2006/12/6 2 1 2 2 2006/12/8 1 1 1 1 2006/12/11 1 1 1 1 1 0 1 1 Subject 2 Examination and application 曰2007/1/17 Right lower 婉1 Left lower wrist Right lower leg Left lower leg 2007/1/19 1 2 1 2007/1/22 1 1 1 1 2006/12/11 0 0 1 1 0 0 1 1

S 20 1379684S 20 1379684

245/Upitl 爲第96119746號中文說明書無劃線修正本 修正日期101年8月2 被試驗者3 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/6 2 2 2 2 2006/12/11 2 2 1 2 2006/12/13 1 0 0 0 被試驗者4 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/15 1 1 1 1 2006/12/18 0 1 0 0 2006/12/20 0 1 0 0 2006/12/22 0 0 0 0 被試驗者5 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2007/1/5 2 2 3 2 2007/1/8 1 1 2 2 2007/1/10 0 0 2 2 2007/1/12 0 0 2 2 被試驗者6 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/18 0 1 3 2 2006/12/11 0 0 2 1 2006/12/13 0 0 1 1 被試驗者7 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/18 1 1 1 1 2006/12/20 0 0 1 1 2006/12/20 0 0 1 1 2006/12/22 0 0 0 1 21 1379684 24!)/Upiil 爲第96119746號中文說明書無劃線修正本 修正日期101年8月2 被試驗者8 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/29 2 3 3 3 2006/12/30 1 2 2 2 2007/1/4 1 0 2 1 被試驗者9 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2007/1/5 0 0 2 3 2007/1/8 0 0 2 1 2007/1/10 0 0 2 1 2007/1/12 0 0 1 1 被試驗者10 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/20 1 1 2 2 2006/12/22 1 0 2 2 2006/12/25 1 0 1 1 2006/12/26 1 0 1 1 2006/12/27 1 0 1 1 被試驗者11 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/4 1 1 2 1 2006/12/6 0 1 1 1 2006/12/8 0 1 1 1 2006/12/26 0 1 0 0 被試驗者12 診察·塗抹曰 右下腕 左下腕 右下腿 左下腿 2006/12/18 0 1 2 1 2006/12/20 0 0 1 1 2006/12/22 0 0 1 1 2006/12/25 0 1 0 0245/Upitl is the Chinese manual of No. 96119746. There is no slash correction. The date of revision is August 2, 2010. The testee 3 The examination, the application, the right lower wrist, the lower left wrist, the lower right leg, the lower left leg 2006/12/6 2 2 2 2 2006/12 /11 2 2 1 2 2006/12/13 1 0 0 0 Subject 4 Examination · Smear 曰 Right lower wrist Left lower wrist Right lower leg Left lower leg 2006/12/15 1 1 1 1 2006/12/18 0 1 0 0 2006/12/20 0 1 0 0 2006/12/22 0 0 0 0 Subject 5 Examination · Smear 曰 Right lower wrist Left lower wrist Right lower leg Left lower leg 2007/1/5 2 2 3 2 2007/1/8 1 1 2 2 2007/1/10 0 0 2 2 2007/1/12 0 0 2 2 The testee 6 examined and smeared 曰 right lower wrist left lower wrist right lower leg left lower leg 2006/12/18 0 1 3 2 2006/12 /11 0 0 2 1 2006/12/13 0 0 1 1 Subject 7 Examination · Smear 曰 Right lower wrist Left lower wrist Right lower leg Left lower leg 2006/12/18 1 1 1 1 2006/12/20 0 0 1 1 2006/12/20 0 0 1 1 2006/12/22 0 0 0 1 21 1379684 24!)/Upiil is the Chinese manual of No. 96119746. There is no slash correction. The date of this amendment is August 201. The testee 8 is inspected and smeared.曰 right lower wrist left lower wrist right lower leg left lower leg 2006/12/29 2 3 3 3 2006/12/30 1 2 2 2 2007/1/4 1 0 2 1 Testee 9 Inspected and smeared 曰 Right lower wrist left lower wrist Right lower leg left lower leg 2007/1/5 0 0 2 3 2007/1/8 0 0 2 1 2007/1/10 0 0 2 1 2007/1/12 0 0 1 1 Subject 10 Examination · Smear 曰 Right lower wrist Left lower wrist Right lower leg Left lower leg 2006/12/20 1 1 2 2 2006/ 12/22 1 0 2 2 2006/12/25 1 0 1 1 2006/12/26 1 0 1 1 2006/12/27 1 0 1 1 Subject 11 Examination and application 曰 Right lower wrist left lower wrist Right lower leg lower left Leg 2006/12/4 1 1 2 1 2006/12/6 0 1 1 1 2006/12/8 0 1 1 1 2006/12/26 0 1 0 0 Testee 12 Inspected and smeared 曰 right lower wrist left lower wrist Right lower leg left lower leg 2006/12/18 0 1 2 1 2006/12/20 0 0 1 1 2006/12/22 0 0 1 1 2006/12/25 0 1 0 0

如上述的診斷評價度所示,被試驗者1〜12的皮膚狀As shown in the above diagnostic evaluation degree, the skin condition of the subjects 1 to 12

S 22 1379684 24570pifl 修正日期101年8月24曰 爲第96119746號中文說明書無劃線修正本 態在塗抹後1周(7曰)之後得到改善。另外,塗抹舞茸萃 取物的護膚霜的改善效果可以在塗抹的1_3日後觀察到。 圖8所示的是被試驗者5在經過塗抹舞茸萃取物的護 膚霜治療前後的照片。塗抹舞茸萃取物的護膚霜後的乾皮 症改善效果從這些照片上可以得到確認。 根據以上結果,證明含有2 wt%的舞茸萃取物的護膚 霜可以對乾皮症有治療效果。 本發明的萃取物具有促進皮脂產生的作用,可作爲化 妝品或藥品使用,有效地治療或改善那些由於皮脂的減少 而引起的皮膚異常·障礙或者皮膚疾患症狀。 雖然本發明已以較佳實施例揭露如上,然其並非用以 限定本發明,任何熟習此技藝者,在不脫離本發明之精神 和範圍内,當可作些許之更動與潤飾,因此本發明之保護 範圍當視後附之申請專利範圍所界定者為準。 【圖式簡單說明】 圖1表示舞茸萃取物以及巴西蘑菇萃取物對豚鼠脂 腺細胞脂肪滴的形成產生的影響作用,其顯示舞茸萃取物 以及巴西蘑菇萃取物對脂腺細胞脂肪滴的形成產生的影 響作用的照片。 圖2表示經舞茸萃取物和巴西蘑菇萃取物處理後的 脉鼠脂腺細胞中皮脂量的動態,其顯示經舞茸萃取物以及 巴西蘑菇萃取物處理之後脂腺細胞中皮脂量動態的圖 表。其中’ **以及***,和沒有經過處理的細胞(C)的顯著 性差異(p<0.01以及0.001) ; ##以及###,和經過胰島素處 23 1379684 24570pifl 修正曰期101年8月24曰 爲第%119746號中文說明書無劃線修1:$; 理細胞的顯著性差異(p<〇〇1,以及〇 〇〇1)。 圖3表示舞茸萃取物和巴西蘑菇萃取物對豚鼠脂腺 細胞的TG量所產生的效果,其顯示舞茸萃取物以及巴西 蘑菇萃取物對皮脂腺細胞中的TG產生效果的圖表。其 中,**以及***,和沒有經過處理的細胞(C)的顯著性差^ (p<0.05以及〇.〇〇1);#、##以及###’和經過胰島素處理 細胞的顯著性差異(p<〇.〇5、0.01以及o.ooi)。 圖4表示使用Oil red 〇染色法評價舞茸萃取物對豚 鼠皮脂腺的皮脂積蓄產生的作用,其顯示舞茸萃取物對皮 鲁 脂腺的皮脂蓄積產生效果的照片。其中,組織切片中的黑 色橢圓是指皮脂腺,用(▲)表示;塗有舞茸萃取物側面; ▲:皮脂腺。 圖5表示使用Oil red Ο染色法評價巴西蘑菇萃取物 對豚鼠皮脂腺的皮脂積蓄產生的作用的評價,其顯示巴西 蘑菇萃取物對皮脂腺的皮脂蓄積產生效果的照片。其中, 組織切片中的黑色橢圓是指皮脂腺,用(▲)表示;* :塗有 巴西蘑兹萃取物側面;▲:皮脂腺。 鲁 圖6A與圖6B表示經舞茸萃取物和巴西磨兹萃取物 處理後豚鼠皮脂腺組織中皮脂量的動態,其顯示經舞茸萃 取物以及巴西蘑菇萃取物處理之後脂腺細胞中皮脂量的 圖表。其中,圖6A是舞茸萃取物處理,圖6B是巴西蘑 菇萃取物處理,而**和***為ρ<〇.〇1以及0.001。 圖7表示經舞茸萃取物處理後豚鼠皮脂腺組織中皮 脂組成的分析,其顯示經舞茸萃取物處理後豚鼠皮脂腺組S 22 1379684 24570pifl Revised date August 24, 2011 For the Chinese manual No. 96191974, there is no slash correction. The state is improved after 1 week (7 曰) after application. In addition, the improvement effect of the skin cream applied with the velvet extract can be observed after 1 to 3 days of application. Fig. 8 is a photograph of the subject 5 before and after the treatment with the mascara extract cream. The dry skin improvement effect of the skin cream after applying the maitake extract can be confirmed from these photographs. Based on the above results, it was confirmed that a skin cream containing 2 wt% of Maitake extract can have a therapeutic effect on dry skin disease. The extract of the present invention has an action of promoting sebum production, and can be used as a cosmetic or a medicine to effectively treat or ameliorate skin abnormalities, disorders, or skin diseases caused by a decrease in sebum. While the present invention has been described in its preferred embodiments, the present invention is not intended to limit the invention, and the present invention may be modified and modified without departing from the spirit and scope of the invention. The scope of protection is subject to the definition of the scope of the patent application. [Simple description of the diagram] Figure 1 shows the effect of Maitake extract and Brazilian mushroom extract on the formation of fat droplets in guinea pig adipose cells, which shows the formation of fat droplets of adipose gland cells by Maitake extract and Brazilian mushroom extract. The effect of the photo. Fig. 2 is a graph showing the dynamics of the amount of sebum in the murine adipose gland cells treated with Maitake extract and Brazilian mushroom extract, which shows a graph of the amount of sebum in the lipocytes after treatment with Maitake extract and Brazilian mushroom extract. Among them, '** and ***, and the untreated cells (C) were significantly different (p < 0.01 and 0.001); ##和###, and after the insulin 23 1379684 24570pifl correction period 101 years 8 Month 24曰 is the No. 119746 Chinese manual without a scribe line: 1:; Significant differences in physiology (p < 〇〇 1, and 〇〇〇 1). Fig. 3 is a graph showing the effect of Maitake extract and Brazilian mushroom extract on the amount of TG in guinea pig adipose cells, which shows a graph showing the effect of Maitake extract and Brazilian mushroom extract on TG production in sebaceous gland cells. Among them, ** and ***, and untreated cells (C) were significantly different (p < 0.05 and 〇. 〇〇 1); #, ##和###' and significantly treated by insulin-treated cells Sexual differences (p<〇.〇5, 0.01 and o.ooi). Fig. 4 is a graph showing the effect of Maitake extract on sebum accumulation in guinea pig sebaceous glands using Oil red 〇 staining, which shows a photograph of the effect of Maitake extract on sebum accumulation in the serotonin gland. Among them, the black ellipse in the tissue section refers to the sebaceous gland, which is represented by (▲); the side of the velvet extract is coated; ▲: sebaceous gland. Fig. 5 is a graph showing the evaluation of the effect of the Brazilian mushroom extract on the sebum accumulation of the guinea pig sebaceous gland using the Oil red Ο staining method, which shows a photograph showing the effect of the Brazilian mushroom extract on the sebum accumulation of the sebaceous gland. Among them, the black ellipse in the tissue section refers to the sebaceous gland, which is represented by (▲); *: the side of the extract of the Brazilian mushroom extract; ▲: the sebaceous gland. Lutu 6A and FIG. 6B show the dynamics of sebum content in guinea pig sebaceous gland tissue after treatment with Maitake extract and Brazilian mill extract, which shows a graph of sebum content in lip gland cells after treatment with Maitake extract and Brazilian mushroom extract. . Here, Fig. 6A is a treatment of Maitake extract, and Fig. 6B is a treatment of a mushroom extract of Brazil, and ** and *** are ρ < 〇.〇1 and 0.001. Figure 7 is a graph showing the analysis of the composition of sebum in the guinea pig sebaceous gland tissue after treatment with Maitake extract, which shows the guinea pig sebaceous gland group treated with Maitake extract.

S 24 1379684 24570pi f1 爲第96丨19746號中文說明書無劃線修正本修正日期101年δ月24日 織中皮脂組成的分析的圖表。ChoE,膽固醇酯(作爲標準 脂質與使用的棕櫚酸膽固醇對應);WaxE ’蠟酯;(作爲標 準脂質與使用的棕櫊酸膽固醇對應);TG,甘油三酯(作爲 標準脂質與使用的棕搁酸膽固醇對應);FFA,游離脂肪酸 (作爲標準脂質與使用的棕櫚酸膽固醇對應” Ch〇,膽固 醇(作爲標準脂質與使用的膽固醇對應)。在統叶處理中。,S 24 1379684 24570pi f1 is the Chinese manual of No. 96丨19746. There is no slash correction. This correction date is the chart of the analysis of the sebum composition in the woven fabric. ChoE, cholesterol ester (corresponding to the standard lipid used as palmitic acid cholesterol); WaxE 'wax ester; (corresponding to standard lipid and palmitic acid cholesterol used); TG, triglyceride (as standard lipid and used brown Acid cholesterol corresponds to) FFA, free fatty acid (corresponding to standard palmitate and palmitate cholesterol used) Ch〇, cholesterol (corresponding to standard lipids as used cholesterol).

量分散分析法統計處理,使用各處理組之間 的有思義的差異鑑定。*和***是顯示在盥 處理的培養⑽鼠皮脂腺細胞(對昭卒取物 比較後有«縣異的絲。成分進行 圖8表示症狀改善例(5號受試驗各、 ) ::提取物的護膚霜治療前後的5號受試驗; 【主要元件符號說明】 無The quantitative dispersive analysis method was used for statistical analysis, and the difference between the treatment groups was used to identify the differences. * and *** are shown in the cultured (10) rat sebaceous gland cells treated with sputum (the sera of the county are compared after the sputum is taken. The composition is shown in Figure 8. The symptoms are improved (No. 5 is tested, respectively) :: Extraction No. 5 test before and after treatment of skin cream; [Key component symbol description]

2525

Claims (1)

1379684 修正日期101年8月24曰 24570pifl 爲第96119746號中文說明書無劃線修正本 七、申請專利範圍: 1. 一種皮脂產生促進物質,是使用以容量計算之酒精 含量大於等於98%的酒精400〜1000重量份,從含水量小 於等於6 wt%的乾燥舞萆(Grif〇la fr〇nd〇sa)的子實體1〇〇 重量份47萃取而得到。 2. —種化妝品’含有如申請專利範圍第1項所述之皮 脂產生促進物質。 3· —種醫藥品’含有如申請專利範圍第1項所述之皮 脂產生促進物質。 4. 一種皮脂產生促進物質的製造方法,包括: 使用以容量計算之酒精含量大於等於98%的酒精 400〜1000重量份,對含水量小於等於6 wt%的乾燥舞茸 (Grifolafrondosa)的子實體1〇〇重量份進行萃取。 5. —種促進皮脂產生用之化妝品的製造方法,包括: 使用以容量計算之酒精含量大於等於98%的酒精 400〜1000重量份,對含水量小於等於6wt%的乾燥舞茸的 子實體100重量份進行萃取。 6. —種促進皮脂產生用之醫藥品的製造方法,包括: 使用以容量計算之酒精含量大於等於98%的酒精 400〜1000重量份,對含水量小於等於6 wt%的乾燥舞茸的 子實體100重量份進行萃取。1379684 Amendment date August 24, 24, 24, pipifl, No. 961, 1974, Chinese manual, no underline correction. 7. Scope of application: 1. A sebum production promoting substance, which uses alcohol with a capacity of 98% or more in terms of capacity. ~1000 parts by weight, obtained by extracting 1 part by weight of a fruit body of dry maiko (Grif〇la fr〇nd〇sa) having a water content of 6 wt% or less. 2. A cosmetic product comprising a sebum production promoting substance as described in claim 1 of the patent application. 3. A pharmaceutical product 'containing a sebum production promoting substance as described in claim 1 of the patent application. A method for producing a sebum production-promoting substance, comprising: using 400 to 1000 parts by weight of alcohol having an alcohol content of 98% or more in terms of capacity, and a fruiting body of dry maitake (Grifolafrondosa) having a water content of 6 wt% or less 1 part by weight for extraction. A method for producing a cosmetic for promoting sebum production, comprising: using 400 to 1000 parts by weight of alcohol having an alcohol content of 98% or more calculated by volume, and a fruiting body 100 of dried Maitake with a water content of 6 wt% or less The parts by weight are extracted. 6. A method for producing a pharmaceutical product for promoting sebum production, comprising: using 400 to 1000 parts by weight of alcohol having an alcohol content of 98% or more calculated by volume, and a dry Maitake mushroom having a water content of 6 wt% or less 100 parts by weight of the solid was extracted.
TW096119746A 2006-06-02 2007-06-01 Maitake mushroom extract and composition containing the same for enhance production of sebum TW200806304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW096119746A TW200806304A (en) 2006-06-02 2007-06-01 Maitake mushroom extract and composition containing the same for enhance production of sebum

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006154912 2006-06-02
TW96106077 2007-02-16
TW096119746A TW200806304A (en) 2006-06-02 2007-06-01 Maitake mushroom extract and composition containing the same for enhance production of sebum

Publications (2)

Publication Number Publication Date
TW200806304A TW200806304A (en) 2008-02-01
TWI379684B true TWI379684B (en) 2012-12-21

Family

ID=38801386

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096119746A TW200806304A (en) 2006-06-02 2007-06-01 Maitake mushroom extract and composition containing the same for enhance production of sebum

Country Status (4)

Country Link
JP (1) JP4677033B2 (en)
KR (2) KR20090029750A (en)
TW (1) TW200806304A (en)
WO (1) WO2007142130A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4583501B2 (en) * 2007-11-13 2010-11-17 株式会社ハイマート Maitake extract and composition for promoting hyaluronic acid (hyaluronan) production containing the same
WO2014008353A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
JP6341661B2 (en) * 2013-12-26 2018-06-13 日本メナード化粧品株式会社 Sebum synthesis accelerator
JP6371520B2 (en) * 2013-12-26 2018-08-08 日本メナード化粧品株式会社 Sebum synthesis accelerator
JP7041913B2 (en) * 2017-08-24 2022-03-25 隆 佐藤 Sebum production promoter
US20220387535A1 (en) 2021-05-26 2022-12-08 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2745056B2 (en) * 1988-10-30 1998-04-28 株式会社ナリス化粧品 Cosmetics
JPH11263732A (en) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd Skin preparation for external use containing mushroom extracts
JP2000319192A (en) * 1999-05-03 2000-11-21 Kirindo:Kk Enzyme inhibitor
EP1170015A1 (en) * 2000-07-06 2002-01-09 Laboratoires Serobiologiques(Societe Anonyme) Use of extracts of the fungus Grifola frondosa

Also Published As

Publication number Publication date
JP4677033B2 (en) 2011-04-27
WO2007142130A1 (en) 2007-12-13
JPWO2007142130A1 (en) 2009-10-22
TW200806304A (en) 2008-02-01
KR20140101875A (en) 2014-08-20
KR20090029750A (en) 2009-03-23

Similar Documents

Publication Publication Date Title
TWI238724B (en) The pharmaceutical and cosmetic composition for increasing skin lipid with the component of vegetable oil
TWI379684B (en)
FR3034314B1 (en) TOPICAL COSMETIC TREATMENT OF SKIN AND SCALP LEATHER AND CORRESPONDING ACTIVE INGREDIENT BASED ON AN EXTRACT FROM APIUM GRAVEOLENS
FR3057462A1 (en) ANIGOZANTHOS FLAVIDUS EXTRACT FOR ITS COSMETIC USE
US11529370B2 (en) Use of composition comprising stem cell-derived exosome as effective ingredient in strengthening skin barrier and improving skin barrier function
JP2022511023A (en) New cosmetic and dermatological uses of extracts of Cistus monsperiensis
KR101638551B1 (en) Improving composition for skin-antiwinkle and skin-whitening, Preparing method thereof, and Skin-externals containing the same
CN108852865A (en) A kind of fullerene topical composition
JP2010520232A (en) External preparation composition containing ginseng extract and its use as a skin moisturizing cosmetic
FR2924609A1 (en) COSMETIC CARE METHOD FOR SENSITIVE SKINS AND COSMETIC COMPOSITIONS FOR SENSITIVE SKIN CARE
JP2016503014A (en) External preparation composition and cosmetic composition for moisturizing skin or improving wrinkles
TW201244731A (en) Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water soluble extract from plant of Solanum genus
JP5577347B2 (en) Cosmetic composition comprising extracts of sasan, kakimoto and herbal medicine
KR101481208B1 (en) Composition for skin external application comprising cryptotanshinone as the active ingredient
CN113171316B (en) Cosmetic for repairing and relieving skin irritation and preparation method thereof
FR2728465A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, CONTAINING A SMELOPHYLLUM CAPENSE EXTRACT
US8637093B2 (en) Composition and uses thereof
US20170020805A1 (en) Cordyceps containing topical skin care formulation
CN115996702A (en) Silybum oil for enhancing skin barrier function
JP3220275B2 (en) Wrinkle improver
KR101864720B1 (en) Composition for preventing, improving or treating skin microrelief damage and atrophoderma comprising Prunella vulgaris extract
KR101822558B1 (en) Cosmetic composition for alleviating skin irritation with apple extract and α-hydroxy acid
WO2023063118A1 (en) Inducer or activator of m2 or m2-like macrophages, method for inducing or activating m2 or m2-like macrophages, composition for preventing and/or ameliorating dermal pigmentation, and method for preventing and/or ameliorating dermal pigmentation
KR100547645B1 (en) A liposome-containing cosmetic composition containing an active ingredient that gives elasticity to the skin
WO2024170760A1 (en) Camellia oleifera tea oil concentrate and uses thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees